The additive effect of alpha-difluoromethylornithine (DFMO) and radiation therapy on a rat glioma model
- PMID: 1548280
- PMCID: PMC12201616
- DOI: 10.1007/BF01410129
The additive effect of alpha-difluoromethylornithine (DFMO) and radiation therapy on a rat glioma model
Abstract
The effects of alpha-difluoromethylornithine (DFMO), radiation and the therapy of their combination were investigated in rats bearing G-XII glioma. DFMO treatment as well as radiation therapy prolonged the survival period when compared to the results in non-treated control rats. The combination therapy showed a greater effect on the survival rate than the single therapies, the effect being additive. The concentration of putrescine, spermidine, and N1-acetylspermidine in tumor tissue was lowered by DFMO, while that of spermine was slightly elevated. Radiation decreased the concentration of all the polyamines, putrescine, spermidine, spermine and N1-acetylspermidine. The concomitant treatment with DFMO and radiation further decreased the concentrations of putrescine and N1-acetylspermidine in tumor tissues. The survival period of glioma-bearing rats is inversely correlated with the tissue levels of putrescine plus N1-acetylspermidine.
Similar articles
-
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450. Health Technol Assess. 2007. PMID: 17999840
-
Congress of Neurological Surgeons systematic review and evidence-based guidelines for the role of chemotherapy in newly diagnosed WHO Grade II diffuse glioma in adults: update.J Neurooncol. 2025 Jan;171(2):279-298. doi: 10.1007/s11060-024-04861-6. Epub 2024 Nov 20. J Neurooncol. 2025. PMID: 39565459
-
alpha-Difluoromethylornithine increases the anti-tumor effect of cis-diamminedichloroplatinum in G-XII rat glioma.Neurol Med Chir (Tokyo). 1995 Apr;35(4):215-20. doi: 10.2176/nmc.35.215. Neurol Med Chir (Tokyo). 1995. PMID: 7596463
-
Polyamines as biomarkers of cervical intraepithelial neoplasia.J Cell Biochem Suppl. 1995;23:87-95. doi: 10.1002/jcb.240590912. J Cell Biochem Suppl. 1995. PMID: 8747382 Clinical Trial.
-
Inhibition of gastric tumorigenesis by alpha-difluoromethylornithine in rats treated with N-methyl-N'-nitro-N-nitrosoguanidine.J Cancer Res Clin Oncol. 1993;119(10):594-8. doi: 10.1007/BF01372722. J Cancer Res Clin Oncol. 1993. PMID: 8335678 Free PMC article.
Cited by
-
Combination treatment of TRAIL, DFMO and radiation for malignant glioma cells.J Neurooncol. 2015 Jun;123(2):217-24. doi: 10.1007/s11060-015-1799-9. Epub 2015 May 3. J Neurooncol. 2015. PMID: 25935110
References
-
- Deen DF, Tofilon PJ (1984) Combined effect of drugs and radiation against tumor cells. In: Rosenblum ML, Wilson CB (eds) Progress in experimental tumor research, vol 28. Brain tumor therapy. Karger, Basel, pp 183–197 - PubMed
-
- Eklint MM (1977) Fundamental questions in the combined use of radiation and chemicals in the treatment of cancer. J Radiat Oncol Phys 5:1711–1720 - PubMed
-
- Harik SI, Sutton CH (1979) Putrescine as a biochemical marker of malignant brain tumor. Cancer Res 39:5010–5015 - PubMed
-
- Heby O, Marton LJ, Wilson CB, Martinetz HM (1975) Polyamine metabolism in a rat brain tumor cell line: its relationship to the growth rate. J Cell Physiol 86:511–522 - PubMed
-
- Hoshino T, Nagashima T, Murovic JA, Wilson CB, Edwards MSB, Gutin PH, Davis RL, Dearmond SJ (1986) In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling. J Neurosurg 64:453–459 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical